Upload
Share
Watch later
Want to use this video for free? Please, contact copyrights holder

First Russian immunoengineering drug against breast cancer passes preclinical trials

Description
Video info

The potential of T-cell therapy is being explored worldwide. It helps strengthen the body’s natural immune system to fight malignant growths. The first specialised Russian drug targets breast cancer.

What is the technology based on? How effective is the new treatment?

Watch our report.

TV BRICS reporter: Aleksandra Duranovskaya

TV BRICS cameraman: Aleksander Martynov

Translated and voiced by Artificial Intelligence.

Photo: TV BRICS


Show more Show less